Roni Shye - January 16, 2018
If you’ve ever been afraid to show up at your doctor’s office because you’ve been “bad” then this post is for YOU! You may think your doctor is “pushing medications on you” especially if you aren’t experiencing any symptoms of the condition they are treating you for. However, their reasoning is not without sound medical and professional judgment.
One of the many reasons you might receive a lecture about the importance of taking your medications is due to the progressive nature of many diseases if not properly treated. See More
Dr. Sharon Orrange - January 16, 2018
Just recently, the American Diabetes Association updated their guidelines to include the recommendation that certain Type 2 Diabetics add to their regimen one of two medications shown to lower the risk of death from stroke and heart disease. Here is the update:
If you are a type 2 diabetic with established heart disease, aka atherosclerotic cardiovascular disease, and your target blood sugars aren’t being met with metformin and diet/exercise add Victoza injections 0r Jardiance. See More
Roni Shye - December 27, 2017
Not all injectable diabetes medications contain insulin. A newer class of medications used for people with type 2 diabetes are considered non-insulin injectables and include drugs like Byetta, Victoza, Bydureon, and Trulicity.
Recently the FDA approved, Ozempic, a new non-insulin injectable for people with type 2 diabetes.
What is Ozempic indicated for?
Ozempic is a medication to be used in addition to a healthy diet and exercise to improve blood sugar control in adults with type 2 diabetes. See More
Roni Shye - November 28, 2017
New medications used to treat type 1 and type 2 diabetes are popping up left and right. From 2013-2016 there have been 15 new oral and injectable medications approved for the treatment of diabetes alone.
What’s noteworthy about this class? There’s a possibility that we might see some oral GLP-1 inhibitors soon! This could mean no more painful injections. See More
Roni Shye - May 31, 2017
Back in July, the FDA approved Adlyxin for diabetes type 2, and it is now available in pharmacies!
When people think about injectable diabetes medications, the first thing that comes to mind tends to be insulin medications like Humalog (insulin lispro) or Lantus (insulin glargine). However, the FDA has been approving many new non-insulin products recently, like Victoza and Byetta, and now Adlyxin!
What is Adlyxin indicated for?
Roni Shye - December 13, 2016
As 2016 comes to a close, we have some news in the world of diabetes medications! The FDA has recently released Soliqua 100/33, a combination medication for the treatment of type 2 diabetes.
Type 2 diabetes can be very tricky and hard to control. Therefore, the discovery and approval of these new oral and injectable medications are important for healthcare providers and their patients.
What is Soliqua 100/33 indicated for?
Soliqua 100/33 is prescribed to improve glycemic control in adults with type 2 diabetes, in conjunction with diet and exercise. See More
Dr. Sharon Orrange - September 12, 2016
The American Diabetes Association recommends that metformin be your first line choice for the treatment of type 2 diabetes. However, if you are on the maximum dose of metformin, or can’t tolerate it, there are many other great alternatives that you may not know of—like Victoza (liraglutide).
Victoza is a brand only medication, given once daily as a subcutaneous injection, and is a great option for overweight type 2 diabetics. See More
Dr. Sharon Orrange - September 06, 2016
Fatty liver disease is now the most common cause of abnormal liver blood tests in the United States. Non-alcoholic fatty liver disease, or NAFLD, is often discovered during a visit to your doctor, with the news that your “liver function blood tests” are abnormal. After being told your AST and ALT blood tests are abnormal you may have a liver ultrasound to confirm fatty liver changes.
NAFLD can lead to cirrhosis—chronic liver damage, that can lead to liver failure—so here are 10 ways to reverse fatty liver. See More
Dr. Sharon Orrange - October 06, 2015
More than 29 million Americans have diabetes. That’s more than 10% of the US—and that number continues to rise. More than 1.7 million adults were diagnosed with diabetes in 2012 alone.
Fortunately, several new medications for diabetes have recently been approved—Toujeo (a new insulin product), Synjardy (a new combination of empagliflozin/metformin) and others. These new drugs provide several benefits such as fewer side effects or foolproof self-dosing with an insulin pen. See More
Roni Shye - May 05, 2015
Did you read our blog on insulin vials and think to yourself, does this apply to my insulin pens too? If so, this post is for you!
With so many different insulin and insulin-like products out there these days it can be hard keep track of how long each of these pens stays good.
Depending on your dose, you may still have insulin left in your pen at the manufacturer-recommended time to throw it away. If this sounds like a familiar situation, know that it is important to throw away your pen regardless of whether you have any leftover. See More